Mesothelioma Information Center
Each year in the United States, approximately 2000 people are diagnosed with mesothelioma. The most important risk factor for mesothelioma is exposure to asbestos.
Although long-term survival with mesothelioma remains poor, researchers continue to explore new approaches to treatment. In addition, advances in supportive care have made mesothelioma treatment more tolerable, leading to improved quality of life.
Understanding mesothelioma treatment options, the role of different doctors specializing in the treatment of mesothelioma, and how and when to access new and innovative mesothelioma treatment options available through clinical trials is essential in order to achieve the best outcome from mesothelioma treatment.
The Cancer Consultants Mesothelioma Information Center has been designed to help patients understand mesothelioma and mesothelioma treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of mesothelioma.
Headline Mesothelioma News 
Approximately 16% of Worldwide Cancers Caused By Preventable Infections
About 16% of cancers worldwide are the result of preventable and treatable infections.
Aspirin Continues to Look Promising for Cancer Prevention
Study reports fewer cases and fewer deaths with daily use.
CancerConnect Live Web Chat with Dr. Barrie Cassileth from Memorial Sloan-Kettering Cancer Center on Complementary Cancer Therapies on Thursday, November 17th at 6PM EST
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service;...
Mesothelioma Tips
Men, Fertility, and Cancer Men who confront a cancer diagnosis before beginning or completing their families...
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Preparing for Surgery You can help ensure that your surgery and recovery go smoothly and that you have...
Mesothelioma Management
Inspiration, Hope & Resources
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Mesothelioma Clinical Trials
CanBasCBP08-01 – Phase I/II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin in Patients with Advanced Solid Tumors and in Chemotherapy-Na?ve Patients with Malignant Pleural Mesothelioma
SDX-102-01 – A Phase II, Open-label, Non-randomized, Multicenter, Single Agent Study of Intravenous SDX-102 for the Treatment of Patients With MTAP-Deficient Cancer
P30-302 – Multicenter Randomized Comparative Phase III Trial of Onconase + Doxorubicin vs Doxorubicin in Patients with Malignant Mesothelioma
 |
 |
 |
 |
